RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 109 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $61,000 | +32.6% | 11,284 | +13.7% | 0.00% | – |
| Q1 2016 | $46,000 | +21.1% | 9,921 | +36.6% | 0.00% | – |
| Q4 2015 | $38,000 | -33.3% | 7,263 | -22.5% | 0.00% | – |
| Q3 2015 | $57,000 | +23.9% | 9,367 | +221.7% | 0.00% | – |
| Q2 2015 | $46,000 | +119.0% | 2,912 | +51.2% | 0.00% | – |
| Q1 2015 | $21,000 | +5.0% | 1,926 | +1.0% | 0.00% | – |
| Q4 2014 | $20,000 | -4.8% | 1,906 | -14.6% | 0.00% | – |
| Q3 2014 | $21,000 | -19.2% | 2,231 | -1.8% | 0.00% | – |
| Q2 2014 | $26,000 | +8.3% | 2,272 | -4.9% | 0.00% | – |
| Q1 2014 | $24,000 | -17.2% | 2,389 | +7.4% | 0.00% | – |
| Q4 2013 | $29,000 | -71.8% | 2,225 | -67.8% | 0.00% | -100.0% |
| Q3 2013 | $103,000 | +212.1% | 6,911 | +93.6% | 0.00% | – |
| Q2 2013 | $33,000 | – | 3,570 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 16,355 | $244,000 | 3.04% |
| EAM Investors, LLC | 175,761 | $2,626,000 | 0.52% |
| Tekla Capital Management LLC | 110,000 | $1,643,000 | 0.18% |
| Jane Street Holding, LLC | 447,456 | $6,676,000 | 0.08% |
| A.R.T. Advisors, LLC | 95,164 | $1,419,000 | 0.08% |
| CREDIT SUISSE AG/ | 5,079,886 | $75,792,000 | 0.08% |
| NOMURA HOLDINGS INC | 736,362 | $10,936,000 | 0.07% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $14,920,000 | 0.04% |
| ROYAL BANK OF CANADA | 2,971,616 | $44,337,000 | 0.03% |
| LORD, ABBETT & CO. LLC | 721,849 | $10,784,000 | 0.02% |